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Background
The emergence of drug resistant HIV strains and suit-
ability of NNRTIs as potent anti-HIV molecules used in
HAART did attract our attention towards developing
NNRTIs. We, therefore, focused on developing some
new NNRTIs utilizing benzimidazole and pyrimidine
moieties to match the hydrophobic nature of the allos-
teric pocket in HIV-RT.
Methods
Compounds designed on the basis of extensive compu-
tational studies, were finally synthesized through facile
synthetic route and characterized using various chroma-
tographic and spectral techniques. All synthesized mole-
cules have been screened against HIV-1 using TZM bl
assay and laboratory adapted strains HIV-1 IIIB (X4,
subtype B), HIV-1 Ada5 (R5, Subtype B) and the pri-
mary isolates HIV-1UG070 (X4, Subtype D).
Results
Cell based assay showed that majority of the compounds
were active at micro molar concentrations (1.39-17.39 µM)
and the SI value ranged between 10.77-17.39 against lab
adapted strains and 5.8–13.91 against primary isolates. The
studies on structure–activity relationship were also consis-
tent with the experimental data.
Conclusions
In view of the results obtained, these compounds may
be developed as potent inhibitors of HIV-1 replication
with suitable structural/pharmacophore modifications.
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